The integrase inhibitors market is an important part of HIV treatment which works by blocking the integrase enzyme and preventing HIV from replicating. Integrase inhibitors such as Raltegravir, Elvitegravir, and Dolutegravir are commonly prescribed as part of combination antiretroviral therapy (cART). These drugs are well-tolerated and have high genetic barriers that make them effective against...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian